JP Patent

JP2024520789A — リポソームアミノグリコシド製剤のインビトロ放出アッセイ法

Assigned to Insmed Inc · Expires 2024-05-24 · 2y expired

What this patent protects

本開示は、リポソームアミノグリコシド製剤、特にリポソームアミカシン製剤のためのインビトロ放出(IVR)法に関する。

USPTO Abstract

本開示は、リポソームアミノグリコシド製剤、特にリポソームアミカシン製剤のためのインビトロ放出(IVR)法に関する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2024520789A
Jurisdiction
JP
Classification
—
Expires
2024-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Insmed Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.